Evidence map›Paper›PMID 34778493›Full record

ArticleHealth services research and managerial epidemiology

A Longitudinal Cohort Study of Emergency Room Utilization Following Mifepristone Chemical and Surgical Abortions, 1999-2015.

James Studnicki, Donna J Harrison, Tessa Longbons, Ingrid Skop, David C Reardon, John W Fisher, Maka Tsulukidze, Christopher Craver

RetractedOpen access · goldAbstract readRetracted Publication
In one paragraph

Article in Health services research and managerial epidemiology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

James StudnickiCharlotte Lozier Institute, Arlington, VA, USA.ORCID https://orcid.org/0000-0003-2958-7493
Donna J HarrisonAmerican Association of Pro-Life Obstetricians and Gynecologists, Eau Claire, MI, USA.
Tessa LongbonsCharlotte Lozier Institute, Arlington, VA, USA.ORCID https://orcid.org/0000-0003-0479-9166
Ingrid SkopCharlotte Lozier Institute, Arlington, VA, USA.
David C ReardonElliot Institute, Springfield, IL, USA.
John W FisherCharlotte Lozier Institute, Arlington, VA, USA.
Maka TsulukidzeFlorida Gulf Coast University, Fort Myers, FL, USA.
Christopher CraverCharlotte Lozier Institute, Arlington, VA, USA.
American Congress of Obstetricians and Gynecologists · USFlorida Gulf Coast University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionExisting research on postabortion emergency room visits is sparse and limited by methods which underestimate the incidence of adverse events following abortion. Postabortion emergency room (ER) use since Food and Drug Administration approval of chemical abortion in 2000 can identify trends in the relative morbidity burden of chemical versus surgical procedures.

objectiveTo complete the first longitudinal cohort study of postabortion emergency room use following chemical and surgical abortions.

methodsA population-based longitudinal cohort study of 423 000 confirmed induced abortions and 121,283 subsequent ER visits occurring within 30 days of the procedure, in the years 1999-2015, to Medicaid-eligible women over 13 years of age with at least one pregnancy outcome, in the 17 states which provided public funding for abortion.

resultsER visits are at greater risk to occur following a chemical rather than a surgical abortion: all ER visits (OR 1.22, CL 1.19-1.24); miscoded spontaneous (OR 1.88, CL 1.81-1.96); and abortion-related (OR 1.53, CL 1.49-1.58). ER visit rates per 1000 abortions grew faster for chemical abortions, and by 2015, chemical versus surgical rates were 354.8 versus 357.9 for all ER visits; 31.5 versus 8.6 for miscoded spontaneous abortion visits; and 51.7 versus 22.0 for abortion-related visits. Abortion-related visits as a percent of total visits are twice as high for chemical abortions, reaching 14.6% by 2015. Miscoded spontaneous abortion visits as a percent of total visits are nearly 4 times as high for chemical abortions, reaching 8.9% of total visits and 60.9% of abortion-related visits by 2015.

conclusionThe incidence and per-abortion rate of ER visits following any induced abortion are growing, but chemical abortion is consistently and progressively associated with more postabortion ER visit morbidity than surgical abortion. There is also a distinct trend of a growing number of women miscoded as receiving treatment for spontaneous abortion in the ER following a chemical abortion.

Indexed as

emergency roominduced abortionMedicaidmedical abortionmifepristone

Identifiers

PMID34778493
PMCPMC8581786
OpenAlexW3213327230

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.